Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Gene|December 4, 2003
Disruption of the PU.1 gene in chicken B lymphoma DT40 cells and its effect on reported target gene expressionHiroki Matsudo, Akira Otsuka, Yukiko Ozawa, et al.Journal of Neuroimmunology|October 17, 2020
Severe worsening of myasthenic symptoms after the eculizumab discontinuationAkiyuki Uzawa, Yukiko Ozawa, Manato Yasuda, et al.Journal of Neuroimmunology|February 27, 2022
Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathyFumiko Oda, Akiyuki Uzawa, Yukiko Ozawa, et al.Acta Neurologica Belgica|January 2, 2023
Minimal symptom expression achievement over time in generalized myasthenia gravisAkiyuki Uzawa, Yukiko Ozawa, Manato Yasuda, et al.Muscle & Nerve|September 14, 2023
Activation of the classical complement pathway in myasthenia gravis with acetylcholine receptor antibodiesYukiko Ozawa, Akiyuki Uzawa, Yosuke Onishi, et al.Journal of Neuroimmunology|January 9, 2023
Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravisHiroyuki Akamine, Akiyuki Uzawa, Yuta Kojima, et al.Journal of Neuroimmunology|September 29, 2023
Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodiesManato Yasuda, Akiyuki Uzawa, Yukiko Ozawa, et al.Neuroreport|May 17, 2021
High mobility group box 1 is involved in the pathogenesis of passive transfer myasthenia gravis modelBibinu Maimaitiming, Akiyuki Uzawa, Yukiko Ozawa, et al.Scandinavian Journal of Immunology|November 19, 2021
Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravisManato Yasuda, Akiyuki Uzawa, Yukiko Ozawa, et al.Journal of the Neurological Sciences|November 5, 2018
Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravisTetsuya Kanai, Akiyuki Uzawa, Naoki Kawaguchi, et al.Pageof 4